Literature DB >> 19915009

N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130.

Georg H Waetzig1, Athena Chalaris, Philip Rosenstiel, Jan Suthaus, Christin Holland, Nadja Karl, Lorena Vallés Uriarte, Andreas Till, Jürgen Scheller, Joachim Grötzinger, Stefan Schreiber, Stefan Rose-John, Dirk Seegert.   

Abstract

N-Linked glycosylation is an important determinant of protein structure and function. The interleukin-6 signal transducer glycoprotein 130 (gp130) is a common co-receptor for cytokines of the interleukin (IL)-6 family and is N-glycosylated at 9 of 11 potential sites. Whereas N-glycosylation of the extracellular domains D1-D3 of gp130 has been shown to be dispensable for binding of the gp130 ligand IL-6 and its cognate receptor in vitro, the role of the N-linked glycans on domains D4 and D6 is still unclear. We have mutated the asparagines of all nine functional N-glycosylation sites of gp130 to glutamine and systematically analyzed the consequences of deleted N-glycosylation (dNG) in both cellular gp130 and in a soluble gp130-IgG1-Fc fusion protein (sgp130Fc). Our results show that sgp130Fc-dNG is inherently unstable and degrades rapidly under conditions that do not harm wild-type sgp130Fc. Consistently, the bulk of cellular gp130-dNG is not transported to the plasma membrane but is degraded in the proteasome. However, the small quantities of gp130-dNG, which do reach the cell surface, are still able to activate the key gp130 signaling target signal transducer and activator of transcription-3 (STAT3) upon binding of the agonistic complex of IL-6 and soluble IL-6 receptor. In conclusion, N-linked glycosylation is required for the stability but not the signal-transducing function of gp130.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19915009      PMCID: PMC2804336          DOI: 10.1074/jbc.M109.075952

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Ultrafast fluorescence depolarisation in the yellow fluorescent protein due to its dimerisation.

Authors:  Gregor Jung; Yingzhong Ma; Bradley S Prall; Graham R Fleming
Journal:  Chemphyschem       Date:  2005-08-12       Impact factor: 3.102

2.  N-glycosylation of the I-like domain of beta1 integrin is essential for beta1 integrin expression and biological function: identification of the minimal N-glycosylation requirement for alpha5beta1.

Authors:  Tomoya Isaji; Yuya Sato; Tomohiko Fukuda; Jianguo Gu
Journal:  J Biol Chem       Date:  2009-03-04       Impact factor: 5.157

3.  Transgenic blockade of interleukin 6 transsignaling abrogates inflammation.

Authors:  Björn Rabe; Athena Chalaris; Ulrike May; Georg H Waetzig; Dirk Seegert; Anwen S Williams; Simon A Jones; Stefan Rose-John; Jürgen Scheller
Journal:  Blood       Date:  2007-11-07       Impact factor: 22.113

4.  An N-glycosylation site on the beta-propeller domain of the integrin alpha5 subunit plays key roles in both its function and site-specific modification by beta1,4-N-acetylglucosaminyltransferase III.

Authors:  Yuya Sato; Tomoya Isaji; Michiko Tajiri; Shumi Yoshida-Yamamoto; Tsuyoshi Yoshinaka; Toshiaki Somehara; Tomohiko Fukuda; Yoshinao Wada; Jianguo Gu
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

5.  N-glycans modulate the activation of gp130 in mouse embryonic neural precursor cells.

Authors:  Makoto Yanagisawa; Robert K Yu
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

Review 6.  N-linked oligosaccharides as outfitters for glycoprotein folding, form and function.

Authors:  Nivedita Mitra; Sharmistha Sinha; Thirumalai N C Ramya; Avadhesha Surolia
Journal:  Trends Biochem Sci       Date:  2006-02-10       Impact factor: 13.807

7.  Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.

Authors:  Stephanie Tenhumberg; Georg H Waetzig; Athena Chalaris; Björn Rabe; Dirk Seegert; Jürgen Scheller; Stefan Rose-John; Joachim Grötzinger
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

8.  Chemical and biological approaches synergize to ameliorate protein-folding diseases.

Authors:  Ting-Wei Mu; Derrick Sek Tong Ong; Ya-Juan Wang; William E Balch; John R Yates; Laura Segatori; Jeffery W Kelly
Journal:  Cell       Date:  2008-09-05       Impact factor: 41.582

9.  The differential impact of disulfide bonds and N-linked glycosylation on the stability and function of CD14.

Authors:  Jianmin Meng; Peggy Parroche; Douglas T Golenbock; C James McKnight
Journal:  J Biol Chem       Date:  2007-12-05       Impact factor: 5.157

Review 10.  The IL-6/sIL-6R complex as a novel target for therapeutic approaches.

Authors:  Stefan Rose-John; Georg H Waetzig; Jürgen Scheller; Joachim Grötzinger; Dirk Seegert
Journal:  Expert Opin Ther Targets       Date:  2007-05       Impact factor: 6.902

View more
  21 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

Review 2.  Glycan changes: cancer metastasis and anti-cancer vaccines.

Authors:  Min Li; Lujun Song; Xinyu Qin
Journal:  J Biosci       Date:  2010-12       Impact factor: 1.826

3.  Molecular characterization and expression analysis of the putative interleukin 6 receptor (IL-6Rα and glycoprotein-130) in rainbow trout (Oncorhynchus mykiss): salmonid IL-6Rα possesses a polymorphic N-terminal Ig domain with variable numbers of two repeats.

Authors:  Maria M Costa; Tiehui Wang; Milena M Monte; Christopher J Secombes
Journal:  Immunogenetics       Date:  2011-10-29       Impact factor: 2.846

4.  Molecular characterization and functional activity of an IL-15 antagonist MutIL-15/Fc human fusion protein.

Authors:  Xiaoyi Yang; Abraham Kallarakal; Nirmala Saptharishi; Hengguang Jiang; Zhiwen Yang; Yueqing Xie; George Mitra; Xin Xiao Zheng; Terry B Strom; Gopalan Soman
Journal:  Mol Pharm       Date:  2013-01-22       Impact factor: 4.939

5.  Stressor-dependent Alterations in Glycoprotein 130: Implications for Glial Cell Reactivity, Cytokine Signaling and Ganglion Cell Health in Glaucoma.

Authors:  Fd Echevarria; Cc Walker; Sk Abella; M Won; Rm Sappington
Journal:  J Clin Exp Ophthalmol       Date:  2013-06-30

6.  Pulmonary instillation of MWCNT increases lung permeability, decreases gp130 expression in the lungs, and initiates cardiovascular IL-6 transsignaling.

Authors:  Leslie C Thompson; Nathan A Holland; Ryan J Snyder; Bin Luo; Daniel P Becak; Jillian T Odom; Benjamin S Harrison; Jared M Brown; Kymberly M Gowdy; Christopher J Wingard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-11-20       Impact factor: 5.464

7.  Extracellular domain N-glycosylation controls human thrombopoietin receptor cell surface levels.

Authors:  Roxana I Albu; Stefan N Constantinescu
Journal:  Front Endocrinol (Lausanne)       Date:  2011-11-11       Impact factor: 5.555

Review 8.  Glycosylation of Immune Receptors in Cancer.

Authors:  Ruoxuan Sun; Alyssa Min Jung Kim; Seung-Oe Lim
Journal:  Cells       Date:  2021-05-04       Impact factor: 6.600

Review 9.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01

10.  TGF-β sensitivity is determined by N-linked glycosylation of the type II TGF-β receptor.

Authors:  Young-Woong Kim; Jinah Park; Hyun-Ju Lee; So-Young Lee; Seong-Jin Kim
Journal:  Biochem J       Date:  2012-08-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.